Molnar Istvan 4
4 · Lantheus Holdings, Inc. · Filed Mar 8, 2021
Insider Transaction Report
Form 4
Molnar Istvan
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-03-04$18.40/sh−4,027$74,097→ 25,130 total - Award
Common Stock
2021-03-04+33,820→ 58,950 total
Footnotes (2)
- [F1]The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.
- [F2]Includes 157 shares acquired under the LNTH employee stock purchase plan on September 11, 2020.